Now showing items 1-3 of 3

  • Schuppan, Detlef; Maki, Markku; Lundin, Knut Erik Aslaksen; Isola, Jorma; Friesing-Sosnik, Tina; Taavela, Juha; Popp, Alina; Koskenpato, Jari; Langhorst, Jost; Hovde, Øistein; Lähdeaho, Marja-Leena; Fucso, Stefano; Schumann, Michael; Török, Helga-Paula; Kupcinskas, Jouzas; Zopf, Yurdagul; Lohse, Ansgar W.; Scheinin, Mika; Kull, Karin; Biedermann, Luc; Byrnes, Valerie; Stellmach, Andreas; Jahnsen, Jørgen; Zeitz, Jonas; Mohrbacher, Ralf; Greinwald, Roland (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)
    Background: In celiac disease, small intestinal transglutaminase 2 causes deamidation of glutamine residues in gluten peptides, which enhances stimulation of T cells and leads to mucosal injury. Inhibition of transglutaminase ...
  • Goel, Gautam; King, Tim; Daveson, A. James; Andrews, Jane M.; Krishnarajah, Janakan; Krause, Richard; Brown, Gregor J.E.; Fogel, Ronald; Barish, Charles F.; Epstein, Roger; Kinney, Timothy P.; Miner, Philip B.; Tye-Din, Jason A.; Girardin, Adam; Taavela, Juha; Popp, Alina; Sidney, John; Mäki, Markku; Goldstein, Kaela E.; Griffin, Patrick H.; Wang, Suyue; Dzuris, John L.; Williams, Leslie J.; Sette, Alessandro; Xavier, Ramnik J.; Sollid, Ludvig Magne; Jabri, Bana; Anderson, Robert P. (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2017)
    Background: A gluten-free diet is the only means to manage coeliac disease, a permanent immune intolerance to gluten. We developed a therapeutic vaccine, Nexvax2, designed to treat coeliac disease. Nexvax2 is an adjuvant-free ...
  • Ludvigsson, Jonas F.; Ciacci, Carolina; Green, Peter H.R.; Kaukinen, Katri; Korponay-Szabó, Ilma R.; Kurppa, Kalle; Murray, Joseph A.; Lundin, Knut Erik Aslaksen; Mäki, Markku J.; Popp, Alina; Reilly, Norelle R.; Rodríguez-Herrera, Alfonso; Sanders, David; Schuppan, Detlef; Sleet, Sarah; Taavela, Juha; Voorhees, Kristin; Walker, Marjorie M.; Leffler, Daniel A. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2018)
    Objective: A gluten-free diet is the only treatment option of coeliac disease, but recently an increasing number of trials have begun to explore alternative treatment strategies. We aimed to review the literature on coeliac ...